Trial Profile
Botox [botulinum toxin A] for non-surgical lateral release in patellofemoral pain.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 25 Oct 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 20 May 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 May 2009 Planned number of patients changed from 20 to 5 as reported by ClinicalTrials.gov.
- 17 Feb 2009 Planned end date changed from 1 Jun 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.